|
1
|
Dexter TM, Spooncer E, Schofield R, Lord
BI and Simmons P: Haemopoietic stem cells and the problem of
self-renewal. Blood Cells. 10:315–339. 1984.PubMed/NCBI
|
|
2
|
Pittenger MF, Mackay AM, Beck SC, Jaiswal
RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and
Marshak DR: Multilineage potential of adult human mesenchymal stem
cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Toma C, Pittenger MF, Cahill KS, Byrne BJ
and Kessler PD: Human mesenchymal stem cells differentiate to a
cardiomyocyte phenotype in the adult murine heart. Circulation.
105:93–98. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sanchez-Ramos J, Song S, Cardozo-Pelaez F,
Hazzi C, Stedeford T, Willing A, Freeman TB, Saporta S, Janssen W,
Patel N, et al: Adult bone marrow stromal cells differentiate into
neural cells in vitro. Exp Neurol. 164:247–256. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim EJ, Kim N and Cho SG: The potential
use of mesenchymal stem cells in hematopoietic stem cell
transplantation. Exp Mol Med. 45:e22013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kern S, Eichler H, Stoeve J, Klüter H and
Bieback K: Comparative analysis of mesenchymal stem cells from bone
marrow, umbilical cord blood, or adipose tissue. Stem Cells.
24:1294–1301. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Le Blanc K, Samuelsson H, Gustafsson B,
Remberger M, Sundberg B, Arvidson J, Ljungman P, Lönnies H, Nava S
and Ringdén O: Transplantation of mesenchymal stem cells to enhance
engraftment of hematopoietic stem cells. Leukemia. 21:1733–1738.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Macmillan ML, Blazar BR, DeFor TE and
Wagner JE: Transplantation of ex-vivo culture-expanded parental
haploidentical mesenchymal stem cells to promote engraftment in
pediatric recipients of unrelated donor umbilical cord blood:
Results of a phase I–II clinical trial. Bone Marrow Transplant.
43:447–454. 2009. View Article : Google Scholar
|
|
9
|
Joo SY, Cho KA, Jung YJ, Kim HS, Park SY,
Choi YB, Hong KM, Woo SY, Seoh JY, Cho SJ and Ryu KH: Mesenchymal
stromal cells inhibit graft-versus-host disease of mice in a
dose-dependent manner. Cytotherapy. 12:361–370. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Le Blanc K, Frassoni F, Ball L, Locatelli
F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger
M, et al: Developmental Committee of the European Group for Blood
and Marrow Transplatation: Mesenchymal stem cells for treatment of
steroid-resistant, severe, acute graft-versus-host disease: A phase
II study. Lancet. 371:1579–1586. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Le Blanc K, Rasmusson I, Sundberg B,
Götherström C, Hassan M, Uzunel M and Ringdén O: Treatment of
severe acute graft-versus-host disease with third party
haploidentical mesenchymal stem cells. Lancet. 363:1439–1441. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dalle Carbonare L, Valenti MT, Zanatta M,
Donatelli L and Lo Cascio V: Circulating mesenchymal stem cells
with abnormal osteogenic differentiation in patients with
osteoporosis. Arthritis Rheum. 60:3356–3365. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang GT, Gronthos S and Shi S:
Mesenchymal stem cells derived from dental tissues vs. those from
other sources: Their biology and role in regenerative medicine. J
Dent Res. 88:792–806. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Blazar BR, Murphy WJ and Abedi M: Advances
in graft-versus-host disease biology and therapy. Nat Rev Immunol.
12:443–458. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Almeida-Porada G, Flake AW, Glimp HA and
Zanjani ED: Cotransplantation of stroma results in enhancement of
engraftment and early expression of donor hematopoietic stem cells
in utero. Exp Hematol. 27:1569–1575. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nolta JA, Hanley MB and Kohn DB: Sustained
human hematopoiesis in immunodeficient mice by cotransplantation of
marrow stroma expressing human interleukin-3: Analysis of gene
transduction of long-lived progenitors. Blood. 83:3041–3051.
1994.PubMed/NCBI
|
|
17
|
Angelopoulou M, Novelli E, Grove JE,
Rinder HM, Civin C, Cheng L and Krause DS: Cotransplantation of
human mesenchymal stem cells enhances human myelopoiesis and
megakaryocytopoiesis in NOD/SCID mice. Exp Hematol. 31:413–420.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ryu KH, Cho KA, Park HS, Kim JY, Woo SY,
Jo I, Choi YH, Park YM, Jung SC and Chung SM: Tonsil-derived
mesenchymal stromal cells: Evaluation of biologic, immunologic and
genetic factors for successful banking. Cytotherapy. 14:1193–1202.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim SJ, Park MH, Moon HJ, Park JH, Ko Y
and Jeong B: Polypeptide thermogels as a three dimensional culture
scaffold for hepatogenic differentiation of human tonsil-derived
mesenchymal stem cells. ACS Appl Mater Interfaces. 6:17034–17043.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lechler RI, Sykes M, Thomson AW and Turka
LA: Organ transplantation - how much of the promise has been
realized? Nat Med. 11:605–613. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bluestone JA, Thomson AW, Shevach EM and
Weiner HL: What does the future hold for cell-based tolerogenic
therapy? Nat Rev Immunol. 7:650–654. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kupcova Skalnikova H: Proteomic techniques
for characterisation of mesenchymal stem cell secretome. Biochimie.
95:2196–2211. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Adler BJ, Kaushansky K and Rubin CT:
Obesity-driven disruption of haematopoiesis and the bone marrow
niche. Nat Rev Endocrinol. 10:737–748. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lai RC, Tan SS, Teh BJ, Sze SK, Arslan F,
de Kleijn DP, Choo A and Lim SK: Proteolytic potential of the MSC
exosome proteome: Implications for an exosome-mediated delivery of
therapeutic proteasome. Int J Proteomics. 2012:9719072012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ranganath SH, Levy O, Inamdar MS and Karp
JM: Harnessing the mesenchymal stem cell secretome for the
treatment of cardiovascular disease. Cell Stem Cell. 10:244–258.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Le Blanc K and Pittenger M: Mesenchymal
stem cells: Progress toward promise. Cytotherapy. 7:36–45. 2005.
View Article : Google Scholar : PubMed/NCBI
|
